
| Revenue | $1 - $10 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Additional NAICS Codes | 334413 Semiconductor Manufacturing 541711 Research & Development in Biotechnology |
| Address | 7201 E Henkel Way Ste 285 Scottsdale, AZ 85255 |
| Spoc Proteomics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $1 - $10 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Spoc Proteomics P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| PRISM Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, cancer, chronic diseases; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medical use; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of disease specific biomarkers; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test media in the form of reagents, cartridges, chips for measuring detection and sequencing of DNA, RNA, polypeptides; Reagents and media for medical and veterinary diagnostic purposes; Veterinary diagnostic reagents | 08/05/2021 |
| FENT Semiconductors; Semiconductor apparatus, namely, devices and testing apparatus for molecular analysis and diagnostics and for readout of DNA data storage and DNA memory; Semiconductor devices; Semiconductor chips; Semiconductor devices, namely, semiconductor life science tool power elements; Semiconductor testing apparatus; Transistors; Transistor testers; Medical laboratory research instruments, namely, diagnostic, examination, and monitoring equipment, namely, tools and instruments for molecular analysis and diagnostics and readout of data stored in DNA or other biopolymers; Software as a Medical Device (SaMD), downloadable, for diagnosing prognosis of diseases, namely, cancer, and precision medicine; Medical laboratory research instruments for molecular analysis and diagnostics and precision medicine | 07/25/2021 |
| PROTEOSCAPE Surgical diagnostic services; Medical diagnostic services; Optical imaging for medical diagnostic use; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing for diagnostic or treatment purposes; Medical analysis services relating to the treatment of persons provided by a medical laboratory | 05/28/2021 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| SYNEXUS CLINICAL RESEARCH US | Tempe, AZ | 100 |
| ARMORWORKS ENTERPRISES | Chandler, AZ | 71 |
| HELIAE DEVELOPMENT | Gilbert, AZ | 25 |
| LAWRENCE SEMICONDUCTOR RESEARCH LABORATORY | Tempe, AZ | 11 |
| CAPSTONE THERAPEUTICS | Tempe, AZ | 7 |
| SAFE | Tempe, AZ | 4 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |